Back
Cue Biopharma Stock Price Chart
Sponsored
CUE
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
CUE
Cue Biopharma
Last Price:
1.05
Seasonality Move:
14.02%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.
Cue Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.2 | Sell |
20-day SMA: | 1.49 | Sell |
50-day SMA: | 1.18 | Sell |
200-day SMA: | 1.37 | Sell |
8-day EMA: | 1.19 | Sell |
20-day EMA: | 1.34 | Sell |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 1.45 | Sell |
Cue Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 37.39 | Sell |
Chaikin Money Flow: | -189943 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 1.76) | Sell |
Bollinger Bands (100): | (0.57 - 1.35) | Buy |
Cue Biopharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cue Biopharma Stock
Is Cue Biopharma Stock a Buy?
- Cue Biopharma share price is 1.02 while CUE 8-day simple moving average is 1.20, which is a Sell signal.
- The stock price of CUE is 1.02 while Cue Biopharma 20-day SMA is 1.49, which makes it a Sell.
- Cue Biopharma 50-day simple moving average is 1.18 while CUE share price is 1.02, making it a Sell technically.
- CUE stock price is 1.02 and Cue Biopharma 200-day simple moving average is 1.37, creating a Sell signal.
CUE Technical Analysis vs Fundamental Analysis
Sell
18
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy or a Sell?
-
Cue Biopharma stock is rated a Sell
The current Cue Biopharma [CUE] share price is $1.02. The Score for CUE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Cue Biopharma Stock Info
Market Cap:
64.62M
Price in USD:
1.02
Share Volume:
265.92K
Cue Biopharma 52-Week Range
52-Week High:
3.25
52-Week Low:
0.45
Sell
18
Cue Biopharma (CUE)
is a Sell
Cue Biopharma Share Price Forecast
-
What is the Cue Biopharma stock price today?
The Cue Biopharma stock price is 1.02 USD today. -
Will CUE stock go up or go down?
Cue Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Cue Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cue Biopharma is overvalued.
Is Cue Biopharma Stock a Buy?
- Cue Biopharma share price is 1.02 while CUE 8-day exponential moving average is 1.19, which is a Sell signal.
- The stock price of CUE is 1.02 while Cue Biopharma 20-day EMA is 1.34, which makes it a Sell.
- Cue Biopharma 50-day exponential moving average is 1.25 while CUE share price is 1.02, making it a Sell technically.
- CUE stock price is 1.02 and Cue Biopharma 200-day simple moving average is 1.45, creating a Sell signal.
Fundamental Analysis of Cue Biopharma
Is Cue Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
Technical Analysis of Cue Biopharma
Should I short Cue Biopharma stock?
- CUE Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Cue Biopharma is a Sell
- Cue Biopharma Relative Strength Index (RSI) is 37.39, which suggest Cue Biopharma is oversold
- The Bollinger Bands (25) for Cue Biopharma is (1.26 - 1.76), which suggest Cue Biopharma is a Buy
- The Bollinger Bands (100) for Cue Biopharma is (0.57 - 1.35), which suggest Cue Biopharma is a Buy
* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.